Signaling Pathway
Tilatamig is a human monoclonal antibody of the IgG1 subtype that specifically targets both EGFR and MET receptors. This dual specificity enables it to interfere with key pathways involved in cellular proliferation and survival, making it a valuable tool for research in cancer biology where these receptors are implicated.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Tilatamig is a human monoclonal antibody of the IgG1 subtype that specifically targets both EGFR and MET receptors. This dual specificity enables it to interfere with key pathways involved in cellular proliferation and survival, making it a valuable tool for research in cancer biology where these receptors are implicated. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
